`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`NALOX-1 PHARMACEUTICALS, LLC,
`Petitioner,
`
`v.
`
`ADAPT PHARMA OPERATIONS LIMITED, and
`OPIANT PHARMACEUTICALS, INC.,
`Patent Owners.
`__________________
`
`Case IPR2019-00694
`U.S. Patent 9,629,965
`__________________
`
`JOINT NOTICE OF STIPULATION
`REGARDING SCHEDULING
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Patent Owners and Petitioner jointly submit this paper to provide notice that
`
`Case IPR2019-00694
`U.S. Patent 9,629,965
`
`
`
`the parties have stipulated to a different date for DUE DATE 3 of the Board’s
`
`Scheduling Order (Paper 11), as amended by the parties’ previous stipulations
`
`regarding scheduling (Papers 14, 29, 36, and 39).
`
`The stipulated DUE DATE is as follows:
`
`
`DUE DATE 3
`
`
`
`Previous Due Date
`April 20, 2020
`
`
`Stipulated Due Date
`April 24, 2020
`
`Presently, all other dates in the Board’s Scheduling Order (as amended) are
`
`to remain the same. However, in light of the challenges posed by the
`
`unprecedented COVID-19 pandemic, the parties may request further changes to the
`
`schedule at a later date.
`
`
`Dated: April 10, 2020
`
`
`
`/Yelee Y. Kim/
`Yelee Y. Kim (Reg. No. 60,088)
`Janine A. Carlan (Reg. No. 42,387)
`Richard Berman (Reg. No. 39,107)
`Bradford Frese (Reg. No. 69,772)
`Christopher Yaen (Reg. No. 66,563)
`ARENT FOX LLP
`1717 K Street NW
`Washington, DC 20006
`Yelee.Kim@arentfox.com
`Janine.Carlan@arentfox.com
`Richard.Berman@arentfox.com
`Bradford.Frese@arentfox.com
`Christopher.Yaen@arentfox.com
`
`Respectfully submitted,
`
`
`/Jessamyn S. Berniker/
`Jessamyn S. Berniker (Reg. No. 72,328)
`Ana C. Reyes (Admitted Pro Hac Vice)
`David M. Krinsky (Reg. No. 72,339)
`Anthony H. Sheh (Reg. No. 70,576)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`jberniker@wc.com
`areyes@wc.com
`dkrinsky@wc.com
`asheh@wc.com
`EmergentNarcan@wc.com
`
`
`2
`
`
`
`
`
`Counsel for Petitioner
`
`
`Case IPR2019-00694
`U.S. Patent 9,629,965
`
`Counsel for Patent Owner
`Adapt Pharma Operations Ltd.
`
`Jessica Tyrus Mackay (Reg. No. 64,742)
`Ann K. Kotze (Reg. No. 76,570)
`GREEN, GRIFFITH & BORG-BREEN, LLP
`676 North Michigan Avenue
`Suite 3900
`Chicago, IL 60611
`jmackay@greengriffith.com
`akotze@greengriffith.com
`
`Counsel for Patent Owner
`Opiant Pharmaceuticals, Inc.
`
`
`3
`
`
`
`Case IPR2019-00694
`U.S. Patent 9,629,965
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certifies that a true
`
`
`
`
`
`and correct copy of the foregoing was served on April 10, 2020 by delivering a
`
`copy via electronic mail on the following attorneys of record:
`
`
`
`
`
`
`
`
`
`
`Yelee Y. Kim
`Janine A. Carlan
`Richard Berman
`Bradford Frese
`Christopher Yaen
`ARENT FOX LLP
`1717 K Street NW
`Washington, DC 20006
`Yelee.Kim@arentfox.com
`Janine.Carlan@arentfox.com
`Richard.Berman@arentfox.com
`Bradford.Frese@arentfox.com
`Christopher.Yaen@arentfox.com
`
`/Jessamyn S. Berniker/
`Jessamyn S. Berniker
`
`
`
`
`
`4
`
`